Indian Pharma Must Shift from Generics to Innovation: Expert
Padmashri Prof G D Yadav urges India's pharma industry to pivot from generics to value-led innovation in drug discovery and AI. NIPER-A awards 211 degrees, announces Rs 100 crore CoE grant.